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Antiandrogens compete with androgens for the androgen receptor (AR) within the 
target organ. However, the precise molecular mechanism of their antagonism is not 
well understood. In this paper we describe the use of limited trypsinization and sucrose 
density gradient centrifugation for the study of androgen receptor conformation and 
interaction with other proteins. 
For this purpose, an in vitro-produced, [35S]methionine-labeled AR was com- 
plexed with ligand at 2 5 T ,  whereafter limited trypsinization was performed. Subse- 
quently, the AR fragments were analyzed on a polyacrylamide gel. A 29-kDa fragment 
of an androgen-bound receptor showed an increased resistance against trypsinization, 
as compared to an unliganded AR. The antiandrogen cyproterone acetate stabilized 
a 35-kDa fragment of the AR against proteolytic degradation (FIG. 1). Similar results 
(not shown) were obtained with several other antiandrogens: hydroxyflutamide, nilu- 
tamide, ICI 176.334 and RU 59063. For a mutated receptor (LNCaP-mutant, codon 
868: Thr to Ala of an AR of 910 amino acids)' agonistic activity of both cyproterone 
acetate and hydroxyflutamide correlated with the formation of the 29-kDa fragment. 
Thus, agonists and antagonists induce different proteolysis-resisting conformations 
of the AR.2 The antiprogestagen RU 486 also has antiandrogenic properties;' after 
binding of RU 486 to the AR, limited trypsinization formed a 25-kDa fragment and 
a minor fragment of 29 kDa (FIG. 1). These results indicate a difference in interaction 
with the AR between the common antiandrogens and RU 486. lmmunoprecipitation 
with a panel of antibodies against the androgen receptor showed that both the 35- 
and 29-kDa fragments contained the entire ligand binding domain, while the 35-kDa 
fragment extended into the hinge region.2 The 25-kDa fragment was truncated at the 
C-terminus of the ligand binding domain, which conforms to results obtained in 
comparable studies on protease susceptibility for the progesterone receptor complexed 
with RU 486.4 When incubation was performed at 0°C (FIG. 2), or in the presence 
of molybdate, both androgens and most antiandrogens stabilized a 35-kDa fragment 
of the AR. In the presence of RU 486 a 35-kDa and 30-kDa fragment of the AR resisted 
trypsinization. These results indicate a change in proteolysis resisting conformation of 
the AR upon warming from 0°C to 25°C for androgens and RU 486, but not for the 
other antiandrogens. The conformational change of the AR may reflect a process 
accompanying the dissociation of heat shock proteins (hsp) from the nonactivated 
hsp-receptor complex. Indeed, sucrose gradient centrifugation showed that an 8S- 
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FIGURE 1. Limited trypsinization of androgen- and antiandrogen-bound AR. In vitro-pro- 
duced, [35S]methionine-labeled AR was incubated (1 h at 25°C) in the presence of ligand before 
limited trypsinization (20 pg trypsidml, 15 min at 25°C). Thereafter the samples were denatured 
and electrophoresed on a 12.5% polyacrylamide gel. Autoradiography was performed overnight.’ 
Lane I represents control (C) without trypsin, lanes 2-5: vehicle (-), dihydrotestos- 
terone (DHT, 10 nM), cyproterone acetate (CA, 1 pM) and RU 486 (1 pM), respectively. 
receptor complex shifted, upon warming, to a 5s complex in the presence of androgens 
and to a 4s complex with RU 486. In the presence of other antiandrogens, an 8S- 
receptor complex was still present after warming (results not shown). 
In conclusion: most antiandrogens increased the stability of the conformation 
around the hinge region of an in vitro-produced androgen receptor, and did not 
dissociate the hsp-receptor complex. RU 486, when bound to the androgen receptor, 
induced an inappropriate conformation at the C-terminus of the ligand binding domain 
and formed a complex with the receptor with a slower sedimentation rate than 
observed for complexes with agonists. 
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